FDA recall D-0015-2024

Product

fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 50 mL, Total fentaNYL 75 mcg/50 mL, 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2080-2

Reason for recall

Lack of assurance of sterility:

Distribution

Nationwide in the USA

Key facts

Status

Terminated

Initiation date

2023-09-21

Report date

2023-10-11

Termination date

2025-03-19

Voluntary/Mandated

Voluntary: Firm initiated

Location

San Diego, CA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0015-2024